Page last updated: 2024-08-23

simvastatin and Nasopharyngeal Carcinoma

simvastatin has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Sun, FR; Sun, LM; Wang, M; Wang, SL	1

Other Studies

1 other study(ies) available for simvastatin and Nasopharyngeal Carcinoma

Article	Year
Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:12 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NF-kappa B; Signal Transduction; Simvastatin	2020

Article

Year

Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.

European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:12

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NF-kappa B; Signal Transduction; Simvastatin

2020